Atlas Trials

A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer

Clinical trial NCT03481920 · TERMINATED

Trial details

NCT number
NCT03481920
Sponsor
PH Research, S.L.
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Start date
2018-01-10
Primary completion
2019-01-10
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.